Trevi Therapeutics, Inc.(TRVI)
Biotechnology
Neuroscience Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-03-26 | SCIASCIA THOMAS Chief Scientific Officer | Sale | -2,631 | -1.17%221,373 | $6.60 | $17,365 | View SEC filing | |
| 2025-03-25 | GOOD JENNIFER L President & CEO | Sale | -5,263 | -2.41%213,313 | $6.58 | $34,625 | View SEC filing | |
| 2025-03-12 | Simon Farrell Chief Commercial Officer | Sale | -81,313 | -51.39%76,900 | $6.75 | $548,878 | View SEC filing | |
| 2024-09-09 | GOOD JENNIFER L President & CEO | Sale | -6,059 | -2.76%213,313 | $3.03 | $18,371 | View SEC filing | |
| 2024-09-05 | GOOD JENNIFER L President & CEO | Sale | -55,121 | -20.53%213,313 | $3.09 | $170,193 | View SEC filing | |
| 2024-08-29 | Meeker David P Director | Sale | -4,555 | -1.28%352,489 | $2.93 | $13,353 | View SEC filing | |
| 2024-08-21 | SCIASCIA THOMAS Chief Scientific Officer | Sale | -16,496 | -6.97%220,315 | $2.96 | $48,883 | View SEC filing | |
| 2024-08-16 | SCIASCIA THOMAS Chief Scientific Officer | Sale | -31,505 | -12.51%220,315 | $2.77 | $87,228 | View SEC filing | |
| 2024-05-31 | SCIASCIA THOMAS Chief Scientific Officer | Sale | -53,368 | -19.93%214,433 | $2.55 | $136,110 | View SEC filing | |
| 2024-05-24 | Delfini Lisa Chief Financial Officer | Sale | -4,350 | -7.55%53,279 | $2.64 | $11,485 | View SEC filing | |
| 2024-05-22 | GOOD JENNIFER L President & CEO | Sale | -25,037 | -10.50%213,313 | $2.86 | $71,576 | View SEC filing | |
| 2024-05-14 | GOOD JENNIFER L President & CEO | Sale | -4,578 | -2.10%213,313 | $2.90 | $13,276 | View SEC filing | |
| 2023-10-12 | Delfini Lisa Chief Financial Officer | Sale | -785 | -2.14%35,901 | $2.02 | $1,586 | View SEC filing | |
| 2023-09-13 | Delfini Lisa Chief Financial Officer | Sale | -711 | -2.03%34,394 | $2.20 | $1,564 | View SEC filing | |
| 2023-08-14 | Delfini Lisa Chief Financial Officer | Sale | -682 | -2.04%32,814 | $2.36 | $1,610 | View SEC filing | |
| 2023-07-12 | Delfini Lisa Chief Financial Officer | Sale | -687 | -2.15%31,204 | $2.34 | $1,608 | View SEC filing | |
| 2023-06-14 | Delfini Lisa Chief Financial Officer | Sale | -610 | -2.02%29,599 | $2.64 | $1,610 | View SEC filing | |
| 2023-05-15 | Delfini Lisa Chief Financial Officer | Sale | -562 | -1.97%27,918 | $2.89 | $1,624 | View SEC filing | |
| 2023-04-12 | Delfini Lisa Chief Financial Officer | Sale | -840 | -3.11%26,189 | $1.84 | $1,545 | View SEC filing | |
| 2023-03-15 | Delfini Lisa Chief Financial Officer | Sale | -892 | -3.48%24,737 | $1.75 | $1,564 | View SEC filing | |
| 2023-02-15 | Delfini Lisa Chief Financial Officer | Sale | -8,474 | -26.64%23,338 | $2.45 | $20,761 | View SEC filing | |
| 2022-07-06 | BONDERMAN DAVID Other | Sale | -500,000 | -11.56%3,824,883 | $2.89 | $1,444,012 | View SEC filing | |
| 2022-07-01 | BONDERMAN DAVID 10% Owner | Sale | -475,966 | -9.91%4,324,883 | $2.77 | $1,318,201 | View SEC filing | |
| 2022-05-04 | BONDERMAN DAVID 10% Owner | Sale | -600 | -0.01%4,800,849 | $2.70 | $1,620 | View SEC filing | |
| 2022-05-02 | BONDERMAN DAVID 10% Owner | Sale | -23,434 | -0.49%4,801,449 | $2.75 | $64,525 | View SEC filing |
1-25 of 76